Homology Medicines
David Park is a Senior Quality Control Analyst at Homology Medicines, Inc. since August 2018, bringing extensive experience from a previous role as QC Analyst II at United Therapeutics Corp, where responsibilities included performing QC GMP assays across various methods such as Size Exclusion Chromatography and ELISA. David holds a Bachelor's Degree in Bioengineering from the University of Maryland College Park, obtained in 2014.
This person is not in any offices